image credit- shutterstock
Mumbai-based Eris Lifesciences, a leading Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in leadership roles in its flagship Domestic Branded Formulations business.
Gopal Agrawal has joined Eris as Vice President and will head up the Renal Care, Branded Injectables and Market Access business segments. Prior to joining Eris, Agrawal was Director, Market Access at Takeda. Prior to Takeda, he has worked with Shire Plc and Eli Lilly. He brings over three decades of rich experience in areas such as Sales, Market Access, Key Account & Tender Management, Pricing & Reimbursement, Public Affairs & Public Health Systems, Patient Advocacy & Services and Patient Support Programs.
Nita Borkar is the co-founder of Oaknet Healthcare and became part of the Eris organisation following the acquisition of Oaknet by Eris in May 2022. Another pharma industry veteran, she co-founded Oaknet in Apr 2015, secured private equity funding for the business and built it into a successful player in the Dermatology space before divesting it to Eris back in 2022. She has now taken on a larger role in Eris and will spearhead the Dermatology, Neuropsychiatry and vitamins/ minerals/nutrients (VMN) businesses. Prior to co-founding Oaknet, Nita has worked with Lupin and Dabur across India, Asia Pacific and the Middle East.
